Pattern of cancer risk in persons with AIDS in Italy in the HAART era.

PubWeight™: 1.95‹?› | Rank: Top 2%

🔗 View Article (PMC 2653754)

Published in Br J Cancer on February 17, 2009

Authors

L Dal Maso1, J Polesel, D Serraino, M Lise, P Piselli, F Falcini, A Russo, T Intrieri, M Vercelli, P Zambon, G Tagliabue, R Zanetti, M Federico, R M Limina, L Mangone, V De Lisi, F Stracci, S Ferretti, S Piffer, M Budroni, A Donato, A Giacomin, F Bellù, M Fusco, A Madeddu, S Vitarelli, R Tessandori, R Tumino, B Suligoi, S Franceschi, Cancer and AIDS Registries Linkage (CARL) Study

Author Affiliations

1: Epidemiology and Biostatistics Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy. epidemiology@cro.it

Articles citing this

Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41

Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33

The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer (2010) 1.32

Reduced risk of prostate cancer in U.S. Men with AIDS. Cancer Epidemiol Biomarkers Prev (2010) 1.23

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS (2012) 1.19

HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc (2011) 1.13

Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer (2011) 1.13

The impact of HAART on HPV-related cervical disease. Curr HIV Res (2010) 1.12

Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem (2010) 1.10

Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07

Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep (2013) 1.06

HIV and cancer in Germany. Dtsch Arztebl Int (2011) 1.05

HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst (2013) 1.02

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. J Int AIDS Soc (2011) 0.99

Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol (2012) 0.97

Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009. J Acquir Immune Defic Syndr (2014) 0.96

Challenges in treating malignancies in HIV in Nigeria. Curr Opin Oncol (2009) 0.96

T cell susceptibility to HIV influences outcome of opportunistic infections. Cell (2013) 0.95

Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92

Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila) (2012) 0.92

Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One (2010) 0.91

Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS One (2014) 0.89

Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection. Curr Opin Oncol (2012) 0.87

Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer (2010) 0.86

Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project. Int J Cancer (2016) 0.84

Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002). Br J Cancer (2009) 0.84

Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases. AIDS Res Ther (2010) 0.82

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. BMC Public Health (2015) 0.81

A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection. J Cancer Res Clin Oncol (2015) 0.80

An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors. Infect Agent Cancer (2012) 0.78

Human immunodeficiency virus-associated lung malignancies. Clin Chest Med (2013) 0.78

The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care. Oncologist (2014) 0.77

The changing landscape of HIV-related lung disease: non-AIDS lung malignancy as a player in the field. Respirology (2014) 0.76

Impact of Human Immunodeficiency Virus in the Pathogenesis and Outcome of Patients with Glioblastoma Multiforme. Brain Tumor Res Treat (2016) 0.76

Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in Nigeria. Infect Agent Cancer (2012) 0.76

Recent trends and future directions in human immunodeficiency virus-associated cancer. Cancer (2010) 0.75

A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis? PLoS One (2014) 0.75

Single-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infection. Mol Clin Oncol (2017) 0.75

Insights on common vaccinations in HIV-infection: efficacy and safety. J Prev Med Hyg (2015) 0.75

Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia. Pan Afr Med J (2017) 0.75

Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study. Malawi Med J (2017) 0.75

Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75

Articles cited by this

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71

Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol (2003) 4.15

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77

Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (2007) 3.30

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood (2006) 2.90

Expanded European AIDS case definition. Lancet (1993) 2.45

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst (2004) 2.23

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19

Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis (2007) 2.00

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS (2008) 1.66

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS (2008) 1.60

The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther (2004) 1.56

Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr (2008) 1.47

Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40

Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer (2003) 1.32

Italian cancer figures--report 2006: 1. Incidence, mortality and estimates. Epidemiol Prev (2006) 1.29

Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer (2003) 1.26

Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS (2004) 1.21

Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr (2003) 1.15

Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol (2003) 1.14

Methodology used for "software for automated linkage in Italy" (SALI). J Biomed Inform (2001) 1.11

Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer (2007) 1.11

Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer (1998) 1.08

Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 0.88

Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev (2006) 0.87

Trends in cancer incidence rates among HIV-infected patients. Clin Infect Dis (2005) 0.86

AIDS case reporting: do we still need it? Lancet (2008) 0.85

Access to gynecological services and Papanicolau tests in HIV-infected Italian women: a questionnaire survey. AIDS Care (2006) 0.84

Articles by these authors

General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (2005) 7.09

The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40

Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol (2001) 3.29

Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol (2007) 3.26

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04

Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81

High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80

Road traffic and adverse respiratory effects in children. SIDRIA Collaborative Group. Occup Environ Med (1998) 2.68

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat (2014) 2.61

Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51

Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res (1990) 2.49

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Reconstitution of simian virus 40 DNA replication with purified proteins. Proc Natl Acad Sci U S A (1990) 2.32

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ (2005) 2.22

European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13

Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13

A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol (2005) 2.09

Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr (2012) 2.08

A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03

HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol (2008) 1.99

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98

Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98

Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94

The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94

Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93

High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS (1996) 1.92

Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J (1979) 1.91

Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91

The impact of parental smoking on asthma and wheezing. SIDRIA Collaborative Group. Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. Epidemiology (1999) 1.90

Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res (1993) 1.88

Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 1.87

"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut (2005) 1.84

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Family history and the risk of stomach and colorectal cancer. Cancer (1992) 1.83

Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis (2001) 1.77

Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer (1998) 1.76

A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76

Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74

Classic kaposi sarcoma: epidemiology and risk factors. Cancer (2000) 1.74

On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72

Biologically active metal-independent superoxide dismutase mimics. Biochemistry (1990) 1.72

Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer (1997) 1.71

Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis. J Epidemiol Community Health (2008) 1.70

A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70

Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol (2003) 1.69

Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68

The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67

Genital warts and cervical neoplasia: an epidemiological study. Br J Cancer (1983) 1.65

Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64

Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64

Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int (2007) 1.64

Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64

Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64

Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62

Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control (1995) 1.61

Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer (1986) 1.61

The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61

Variations in the survival of adult cancer patients in Italy. Tumori (1997) 1.60

Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59

Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol (2000) 1.59

Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59

Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst (1998) 1.58

Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58

Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol (1994) 1.56

Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer (2000) 1.56

Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55

Petrous bone cholesteatoma. Skull Base Surg (1993) 1.55

Risk factors for myocardial infarction in young women. Am J Epidemiol (1987) 1.55

The impact of the summer 2003 heat waves on mortality in four Italian cities. Euro Surveill (2005) 1.55

Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study. Eur J Cancer (1998) 1.54

Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A (1992) 1.54

Loss and/or formation of antioxidants during food processing and storage. Cancer Lett (1997) 1.54

DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54